相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients
Kristina Petruliene et al.
MEDICINA-LITHUANIA (2017)
Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients
Kristina Petruliene et al.
MEDICINA-LITHUANIA (2017)
Modulation of TRP Channel Activity by Hydroxylation and Its Therapeutic Potential
Yagnesh Nagarajan et al.
PHARMACEUTICALS (2017)
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD
Nupur Gupta et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2017)
Excess mortality attributable to chronic kidney disease. Results from the PIRP project
Dino Gibertoni et al.
JOURNAL OF NEPHROLOGY (2016)
Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia
Louis Holdstock et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients
Anatole Besarab et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia
William Nseir et al.
JOURNAL OF DIABETES (2016)
A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial
Richard A. Brigandi et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6-to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
Robert Provenzano et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2016)
Iron therapy in chronic kidney disease: Recent changes, benefits and risks
Sandra Ribeiro et al.
BLOOD REVIEWS (2016)
Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism
Annelies Quaegebeur et al.
CELL METABOLISM (2016)
Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
Robert Provenzano et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Conditional Deletion of Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Gene Reveals Its Essential Role in Chondrocyte Function and Endochondral Bone Formation
Shaohong Cheng et al.
ENDOCRINOLOGY (2016)
Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia
Elke Marsch et al.
EUROPEAN HEART JOURNAL (2016)
Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
Mun Chiang Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells
Martina Rauner et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Association of Increased Serum Ferritin With Impaired Muscle Strength/Quality in Hemodialysis Patients
Chie Nakagawa et al.
JOURNAL OF RENAL NUTRITION (2016)
Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease
Pablo E. Pergola et al.
KIDNEY INTERNATIONAL (2016)
Impact of Oxidative Stress in Premature Aging and Iron Overload in Hemodialysis Patients
Blanca Murillo-Ortiz et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Safety Issues in Iron Treatment in CKD
Nosratola D. Vaziri
SEMINARS IN NEPHROLOGY (2016)
Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice
Amandine Thomas et al.
SCIENTIFIC REPORTS (2016)
Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing
Angelo Karaboyas et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Oral Delivery of Prolyl Hydroxylase Inhibitor: AKB-4924 Promotes Localized Mucosal Healing in a Mouse Model of Colitis
Ellen Marks et al.
INFLAMMATORY BOWEL DISEASES (2015)
Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis
Liang Xie et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality
George R. ' Bailie et al.
KIDNEY INTERNATIONAL (2015)
Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia
Muhammad T. Rishi et al.
MICROVASCULAR RESEARCH (2015)
Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes
Yutaka Tojo et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
So Yeon Kim et al.
MOLECULES (2015)
Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
Anatole Besarab et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Secondary haemochromatosis in a haemodialysis patient
Lu Cheng et al.
SINGAPORE MEDICAL JOURNAL (2015)
Negative regulation of HIF in skeletal muscle of elite endurance athletes: a tentative mechanism promoting oxidative metabolism
M. E. Lindholm et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2014)
Targeted Gene Deletion of Prolyl Hydroxylase Domain Protein 3 Triggers Angiogenesis and Preserves Cardiac Function by Stabilizing Hypoxia Inducible Factor 1 Alpha Following Myocardial Infarction
Babatunde Oriowo et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE
Simon D. Roger et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)
Magnetic Resonance Imaging Repercussions of Intravenous Iron Products Used for Iron-Deficiency Anemia and Dialysis-Associated Anemia
Guy Rostoker et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2014)
Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients
Takahiro Kuragano et al.
KIDNEY INTERNATIONAL (2014)
Identification of erythroferrone as an erythroid regulator of iron metabolism
Leon Kautz et al.
NATURE GENETICS (2014)
Prevalence of Anemia in Chronic Kidney Disease in the United States
Melissa E. Stauffer et al.
PLOS ONE (2014)
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
Anne-Theres Henze et al.
NATURE COMMUNICATIONS (2014)
Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
Ioannis Koulouridis et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
HIF-1α is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2α-induced excessive erythropoiesis
Kristin Franke et al.
BLOOD (2013)
Regulation of erythropoiesis by hypoxia-inducible factors
Volker H. Haase
BLOOD REVIEWS (2013)
Erythrocytosis and Pulmonary Hypertension in a Mouse Model of Human HIF2A Gain of Function Mutation
Qiulin Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A Knock-in Mouse Model of Human PHD2 Gene-associated Erythrocytosis Establishes a Haploinsufficiency Mechanism
Patrick R. Arsenault et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes
Cullen M. Taniguchi et al.
NATURE MEDICINE (2013)
Kidney Disease Improving Global Outcomes (Kdigo) Guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice (Erbp) Position Statement
Francesco Locatelli et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Regulation of IL-1β-induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways
Carsten C. Scholz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Iron Sucrose Promotes Endothelial Injury and Dysfunction and Monocyte Adhesion/Infiltration
Vaijinath S. Kamanna et al.
AMERICAN JOURNAL OF NEPHROLOGY (2012)
Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis
Qingdu Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy
Martin Mollenhauer et al.
LANGENBECKS ARCHIVES OF SURGERY (2012)
Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients
Kirsten L. Johansen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
Ko-Lin Kuo et al.
PLOS ONE (2012)
ANAEMIA, DIABETES AND CHRONIC KIDNEY DISEASE: WHERE ARE WE NOW?
P. E. Stevens
JOURNAL OF RENAL CARE (2012)
Disruption of Hypoxia-Inducible Transcription Factor-Prolyl Hydroxylase Domain-1 (PHD-1-/-) Attenuates Ex Vivo Myocardial Ischemia/Reperfusion Injury Through Hypoxia-Inducible Factor-1α Transcription Factor and Its Target Genes in Mice
Ram Sudheer Adluri et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression
Victor R. Gordeuk et al.
BLOOD (2011)
Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease: A Randomized Trial
Eldrin F. Lewis et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Anemia, inflammation and health-related quality of life in chronic kidney disease patients
Y. M. K. Farag et al.
CLINICAL NEPHROLOGY (2011)
HIF prolyl hydroxylase inhibitors for anemia
Eugene Muchnik et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis
Manuel Munoz et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Hypoxia-Inducible Factor-1α-Dependent Protection from Intestinal Ischemia/Reperfusion Injury Involves Ecto-5′-Nucleotidase (CD73) and the A2B Adenosine Receptor
Melanie L. Hart et al.
JOURNAL OF IMMUNOLOGY (2011)
Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study
Tadao Akizawa et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
Jodie L. Babitt et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia
Pinelopi P. Kapitsinou et al.
BLOOD (2010)
The Therapeutic Potential of Erythropoiesis-Stimulating Agents for Tissue Protection: A Tale of Two Receptors
Michael Brines
BLOOD PURIFICATION (2010)
The Asparaginyl Hydroxylase Factor Inhibiting HIF-1α Is an Essential Regulator of Metabolism
Na Zhang et al.
CELL METABOLISM (2010)
Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury
Martin Schneider et al.
GASTROENTEROLOGY (2010)
Loss of Prolyl Hydroxylase-1 Protects Against Colitis Through Reduced Epithelial Cell Apoptosis and Increased Barrier Function
Murtaza M. Tambuwala et al.
GASTROENTEROLOGY (2010)
Erythrocytosis associated with a novel missense mutation in the HIF2A gene
Richard van Wijk et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Hypoxia-inducible factor-2α-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization
Alexander Paliege et al.
KIDNEY INTERNATIONAL (2010)
Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes.
Scott D. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Erythropoietin stimulating agents in the management of anemia of chronic kidney disease
Moro Salifu
Patient Preference and Adherence (2010)
Role of the intracellular localization of HIF-prolyl hydroxylases
Ken-ichi Yasumoto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Altitude and All-Cause Mortality in Incident Dialysis Patients
Wolfgang C. Winkelmayer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Erythrocytosis-associated HIF-2α Mutations Demonstrate a Critical Role for Residues C-terminal to the Hydroxylacceptor Proline
Paul W. Furlow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
David R. Mole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Proteomics-based Identification of Novel Factor Inhibiting Hypoxia-inducible Factor (FIH) Substrates Indicates Widespread Asparaginyl Hydroxylation of Ankyrin Repeat Domain-containing Proteins
Matthew E. Cockman et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins
Kotaro Takeda et al.
BLOOD (2008)
Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2α mutation
Daniel P. Gale et al.
BLOOD (2008)
Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
Laura Silvestri et al.
BLOOD (2008)
Role and regulation of prolyl hydroxylase domain proteins
G-H Fong et al.
CELL DEATH AND DIFFERENTIATION (2008)
The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis
Eoin P. Cummins et al.
GASTROENTEROLOGY (2008)
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition
Andreas Robinson et al.
GASTROENTEROLOGY (2008)
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis
Maurizio Martini et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
The Angiopoietin-2 Gene of Endothelial Cells is Up-Regulated in Hypoxia by a HIF Binding Site Located in Its First Intron and by the Central Factors GATA-2 and Ets-1
Marie-Pierre Simon et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
The effect of altitude on dosing and response to erythropoietin in ESRD
M. Alan Brookhart et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Abnormal sympathoadrenal development and systemic hypotension in PHD3-/- mice
Tammie Bishop et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Hypoxia-inducible factor-1 alpha stabilization in nonhypoxic conditions: Role of oxidation and intracellular ascorbate depletion
Elisabeth L. Page et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
A gain-of-function mutation in the HIF2A gene in familial erythrocytosis
Melanie J. Percy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways
Xiaofeng Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia
Marta Bosch-Marce et al.
CIRCULATION RESEARCH (2007)
Epoetin-induced pure red cell aplasia: diagnosis and treatment
Lain C. Macdougall
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2007)
Iron overload and immunity
Graca Porto et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Asparaginyl hydroxylation of the notch ankyrin repeat domain by factor inhibiting hypoxia-inducible factor
Mathew L. Coleman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Essential role for prolyl hydroxylase domain protein 2 in oxygen Homeostasis of the adult vascular system
Kotaro Takeda et al.
CIRCULATION (2007)
The role of iron in diabetes and its complications
Sundararaman Swaminathan et al.
DIABETES CARE (2007)
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Carole Peyssonnaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells
Ryo Fukuda et al.
CELL (2007)
Acute postnatal ablation of Hif-2α results in anemia
Michaela Gruber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay
Dominic Ehrismann et al.
BIOCHEMICAL JOURNAL (2007)
Correction of anemia with epoetin alfa in chronic kidney disease
Ajay K. Singh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
Tilman B. Drueke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-α
F Dayan et al.
CANCER RESEARCH (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Inflammation in end-stage renal disease: The hidden enemy
P Stenvinkel
NEPHROLOGY (2006)
A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis
MJ Percy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues
EJ Soilleux et al.
HISTOPATHOLOGY (2005)
HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability
JS Isaacs et al.
CANCER CELL (2005)
FEF-2α regulates murine hematopoietic development in an erythropoietin-dependent manner
M Scortegagna et al.
BLOOD (2005)
Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease
KA Reis et al.
INTERNATIONAL HEART JOURNAL (2005)
Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1 - Impact on the bioactivation of proproteins
S McMahon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase
MA Selak et al.
CANCER CELL (2005)
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis
J Karhausen et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor
RJ Appelhoff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Oxidative stress in uremia: Nature, mechanisms, and potential consequences
ND Vaziri
SEMINARS IN NEPHROLOGY (2004)
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
DJ Ceradini et al.
NATURE MEDICINE (2004)
Congenital disorder of oxygen sensing:: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors
VR Gordeuk et al.
BLOOD (2004)
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity
R Deicher et al.
KIDNEY INTERNATIONAL (2003)
Hypoxia rapidly activates HIF-3a mRNA expression
M Heidbreder et al.
FASEB JOURNAL (2003)
Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions
R Minqin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Widespread, hypoxia-inducible expression of HIF-2α in distinct cell populations of different organs
MS Wiesener et al.
FASEB JOURNAL (2002)
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
SO Ang et al.
NATURE GENETICS (2002)
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease
T Drüeke et al.
CIRCULATION (2002)
Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family
KS Hewitson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor
D Lando et al.
GENES & DEVELOPMENT (2002)
Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch
D Lando et al.
SCIENCE (2002)
Mammalian EGLN genes have distinct patterns of mRNA expression and regulation
ME Lieb et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2002)
Transcription factor HIF-1 is a necessary mediator of the pasteur effect in mammalian cells
TN Seagroves et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency
CK Mukhopadhyay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
